Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis

[1]  R. Salomon,et al.  Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  Ran Wang,et al.  Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura. , 2017, Clinical biochemistry.

[3]  A. Jamin,et al.  New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). , 2017, Autoimmunity reviews.

[4]  A. Jamin,et al.  Biomarkers of IgA vasculitis nephritis in children , 2017, PloS one.

[5]  A. Bygum,et al.  Henoch-Schönlein Purpura: A Literature Review. , 2017, Acta dermato-venereologica.

[6]  E. Thervet,et al.  Characteristics and Management of IgA Vasculitis (Henoch‐Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey , 2017, Arthritis & rheumatology.

[7]  L. Kemény,et al.  Neutrophil‐to‐lymphocyte ratio: a biomarker for predicting systemic involvement in adult IgA vasculitis patients , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  Cheng Zhu,et al.  L-selectin mechanochemistry restricts neutrophil priming in vivo , 2017, Nature Communications.

[9]  M. Erol,et al.  The Relationship of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Gastrointestinal Bleeding in Henoch-Schonlein Purpura , 2016, Iranian journal of pediatrics.

[10]  Rohit Sharma.  Revised International Chapel Hill Consensus Conference nomenclature of vasculitides , 2016, Radiopaedia.org.

[11]  D. Han,et al.  The Optimal Cut-Off Value of Neutrophil-to-Lymphocyte Ratio for Predicting Prognosis in Adult Patients with Henoch–Schönlein Purpura , 2016, PloS one.

[12]  S. Čučnik,et al.  IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults , 2016, Arthritis Research & Therapy.

[13]  G. Opdenakker,et al.  Serum amyloid A1α induces paracrine IL‐8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils , 2015, Journal of leukocyte biology.

[14]  S. Čučnik,et al.  Patient age, gender and extent of purpura may suggest short-term outcomes in adults with IgA vasculitis. , 2015, Rheumatology.

[15]  E. Thervet,et al.  IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects. , 2015, Autoimmunity reviews.

[16]  H. Yang,et al.  Laboratory Markers Indicating Gastrointestinal Involvement of Henoch-Schönlein Purpura in Children , 2015, Pediatric gastroenterology, hepatology & nutrition.

[17]  Zhangsuo Liu,et al.  Comparison between adults and children with Henoch–Schönlein purpura nephritis , 2015, Pediatric Nephrology.

[18]  Q. Ye,et al.  Relationship between Immune Parameters and Organ Involvement in Children with Henoch-Schonlein Purpura , 2014, PloS one.

[19]  M. Tomšič,et al.  Incidence of IgA vasculitis in the adult Slovenian population , 2014, The British journal of dermatology.

[20]  M. Duman,et al.  The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch–Schonlein purpura , 2014, Rheumatology International.

[21]  Yong-Beom Park,et al.  Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura , 2014, Journal of Korean medical science.

[22]  M. Perretti,et al.  Investigational Analysis Reveals a Potential Role for Neutrophils in Giant-Cell Arteritis Disease Progression , 2014, Circulation research.

[23]  M. González-Gay,et al.  Henoch-Schönlein Purpura in Northern Spain , 2014, Medicine.

[24]  栄一 末松.  血管炎の新分類2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides , 2013 .

[25]  T. Kawakami,et al.  Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch–Schönlein purpura , 2013, Clinical and experimental dermatology.

[26]  A. Mahr,et al.  Epidemiology of immunoglobulin A vasculitis (Henoch–Schönlein): current state of knowledge , 2013, Current opinion in rheumatology.

[27]  H. Hsu,et al.  Identification and characterization of IgA antibodies against β2‐glycoprotein I in childhood Henoch–Schönlein purpura , 2012, The British journal of dermatology.

[28]  Y. Li,et al.  Serum Amyloid A Levels Associated with Gastrointestinal Manifestations in Henoch-Schönlein Purpura , 2012, Inflammation.

[29]  K. Penny,et al.  An epidemiological study of Henoch-Schönlein purpura. , 2010, Paediatric nursing.

[30]  A. Bakkaloğlu,et al.  EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria , 2010, Annals of the rheumatic diseases.

[31]  Yao-Hsu Yang,et al.  Clinical manifestations and outcomes of Henoch-Schönlein purpura: comparison between adults and children. , 2009, Pediatrics and neonatology.

[32]  B. Chiang,et al.  Circulating IgA from acute stage of childhood Henoch‐Schönlein purpura can enhance endothelial interleukin (IL)‐8 production through MEK/ERK signalling pathway , 2006, Clinical and experimental immunology.

[33]  B. Chiang,et al.  Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells , 2004, Annals of the rheumatic diseases.

[34]  A. Stadnyk,et al.  Neutrophils migrate across intestinal epithelium using β2 integrin (CD11b/CD18)‐independent mechanisms , 2004, Clinical and experimental immunology.

[35]  M. González-Gay,et al.  Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. , 2002, Seminars in arthritis and rheumatism.

[36]  B. Chiang,et al.  The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF‐α treatment in children with Henoch–Schönlein purpura , 2002, Clinical and experimental immunology.

[37]  E. Thervet,et al.  Henoch-Schönlein Purpura in adults: outcome and prognostic factors. , 2002, Journal of the American Society of Nephrology : JASN.

[38]  K. Zen,et al.  Signal Regulatory Protein (SIRPα), a Cellular Ligand for CD47, Regulates Neutrophil Transmigration* , 2002, The Journal of Biological Chemistry.

[39]  T. Mayadas,et al.  Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. , 2001, Blood.

[40]  N. Hotchin,et al.  Role of the cytoskeleton in rapid activation of CD11b/CD18 function and its subsequent downregulation in neutrophils. , 2000, Journal of cell science.

[41]  A. Bakkaloğlu,et al.  The role of cytokines in Henoch Schonlein purpura. , 1997, Scandinavian journal of rheumatology.

[42]  S. Colgan,et al.  CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia , 1996, The Journal of cell biology.